Back to School: How biopharma can reboot drug development. Access exclusive analysis here

RMP-7 drug delivery system with carboplatin data

ALKS (Cambridge, Mass.) completed three Phase I/II studies of RMP-7, a molecule that increases permeability of the blood-brain barrier, in combination with carboplatin.

At the Hambrecht & Quist Life

Read the full 290 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE